Overview of IBA’s Shareholder Disclosure
In recent announcements, IBA (Ion Beam Applications S.A.) has published detailed information concerning its capital and voting rights under applicable regulations. This publication, essential for maintaining transparency with shareholders and market participants, adheres to the legal framework established for entities listed on regulated markets.
Capital and Voting Rights
According to current disclosures, the total capital of IBA stands at €42,502,318.54. This figure represents the financial backbone of the company, vital for understanding its health and capacity for growth. Voting rights play a crucial role within corporate governance, and as reported, the number of securities conferring the right to vote amounts to 30,282,218.
Understanding Voting Rights
Understanding the implications of voting rights is crucial for stakeholders. Of the total voting rights, there are shares with loyalty voting rights, totaling 10,232,401. This mechanism of loyalty voting is designed to reward long-term shareholders by allowing them greater influence in corporate governance.
Calculation of Existing Voting Rights
The existing voting rights are calculated using the formula [A-B+(B*2)], resulting in a total of 40,514,619 voting rights. This number forms the basis for any notifications concerning significant ownership changes, which are subject to regulatory scrutiny under national laws.
Legal and Statutory Thresholds
The statutory thresholds for shareholder notifications are set at various levels including 1%, 2%, 3%, and moving up to 35%. Each threshold signifies critical points at which shareholders must notify the company of their holdings, thereby maintaining a level of transparency in the market.
Contact Information for Shareholder Inquiries
For any inquiries related to shareholder voting rights or to report threshold crossings, interested parties can reach out to the designated contact at IBA via email at shareholderrelations@iba-group.com. Having clear communication channels allows for smoother interactions between the company and its investors.
Insights into IBA
IBA is recognized as a pioneer in particle accelerator technology, leading the way in sectors such as proton therapy, which represents the cutting edge of radiation therapy today. The company also excels in industrial sterilization and radiopharmaceutical development, employing around 2,100 individuals globally. As a certified B Corporation, IBA proudly meets rigorous standards for social and environmental accountability.
Seeking Further Information
For more detailed information about the company’s activities and initiatives, visit IBA's website at www.iba-worldwide.com. Engaging with their resources can provide deeper insights into their innovations and contributions to healthcare.
Frequently Asked Questions
What information did IBA publish recently?
IBA published details about its total capital, voting rights, and thresholds for shareholder notifications.
How is the existing voting rights calculated?
Existing voting rights are calculated with the formula [A-B+(B*2)], leading to a total of 40,514,619 voting rights.
What thresholds apply for shareholder notifications?
Shareholders must notify IBA when their holdings cross 1%, 2%, 3%, up to 35% ownership thresholds.
How can I contact IBA for shareholder matters?
You can contact IBA at shareholderrelations@iba-group.com for any inquiries.
What industries does IBA operate in?
IBA operates primarily in the healthcare sector, focusing on proton therapy, radiopharmaceuticals, industrial sterilization, and dosimetry.
